Health & Biotech
Stories by Hugo Gray, The Green Fund
Health & Biotech
‘Tidal wave of demand’: There’s a pot shortage in New York
Health & Biotech
US growing approvals a ‘monumental’ step away from Trump moratorium on pot licensing
Health & Biotech
Confusion and selloff as Credit Suisse pulls plug on US cannabis stocks
Health & Biotech
Phillip Morris mulls cannabis, pot market gets up off the couch… almost
Health & Biotech
US banks closer to legally doing business with cannabis, as ASX-listed Incannex pushes its way into the country
Health & Biotech
Canadian cannabis giants Aphria and Tilray closer to merger; ASX cannabis stock Bod snares new CFO
Health & Biotech
Virginia first southern US state to legalise cannabis, ASX-listed Medlab gets first nod from Europe patent office
Health & Biotech
It looks like 2021 will be the Year of Cannabis Legalisation in the US
Health & Biotech
NY finally on cannabis bandwagon, as ASX-listed Creso Pharma boosts coffers by $18 million
Health & Biotech
US cannabis market gets major boost as SAFE Act is put in front of legislators once again
Health & Biotech